Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIHEPTANOIN vs TRILACICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRIHEPTANOIN vs TRILACICLIB: Safety Overview

Metric TRIHEPTANOIN TRILACICLIB
Total FAERS Reports 502 226
Deaths Reported 59 29
Death Rate 11.8% 12.8%
Hospitalizations 242 96
Average Patient Age 13.5 yrs 62.2 yrs
% Female Patients 49.9% 43.9%
FDA Approval Date Jun 30, 2020 Feb 12, 2021
Manufacturer Ultragenyx Pharmaceutical Inc. Pharmacosmos Therapeutics Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription